{"id":394038,"date":"2020-12-07T07:03:13","date_gmt":"2020-12-07T12:03:13","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=394038"},"modified":"2020-12-07T07:03:13","modified_gmt":"2020-12-07T12:03:13","slug":"gw-pharmaceuticals-to-present-at-the-2020-needham-virtual-epilepsy-pain-specialty-cns-therapeutics-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/gw-pharmaceuticals-to-present-at-the-2020-needham-virtual-epilepsy-pain-specialty-cns-therapeutics-conference\/","title":{"rendered":"GW Pharmaceuticals to Present at the 2020 Needham Virtual Epilepsy &amp; Pain \u2013 Specialty CNS Therapeutics Conference"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">LONDON and CARLSBAD, Calif., Dec.  07, 2020  (GLOBE NEWSWIRE) &#8212; GW Pharmaceuticals plc (NASDAQ: GWPH, GW, the Company or the Group), a world leader in the science, development, and commercialization of cannabinoid prescription medicines, today announced that the Company will present at the Needham Virtual Epilepsy &amp; Pain \u2013 Specialty CNS Therapeutics Conference on Thursday, December 10, 2020 at 11:00am EST.<\/p>\n<p align=\"justify\">A live audio webcast of the presentation will be available through GW\u2019s corporate website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=aIFIFX6PhIu_3gvLYSIqTMBbur_Vgaw1QN5D0y_Xxl4iWMAF-D7xaF34ArR7OwJEAPDkZYTIGQQ5rfhaOwxfpA==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">www.gwpharm.com<\/a> in the Investors section under Events &amp; Presentations. A replay will be available soon after the live presentation.<\/p>\n<p align=\"justify\">\n        <strong>About GW Pharmaceuticals plc and Greenwich Biosciences, Inc.<\/strong><br \/>\n        <br \/>Founded in 1998, GW is a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform in a broad range of disease areas. The Company\u2019s lead product, EPIDIOLEX<sup>\u00ae<\/sup>\u00a0(cannabidiol) oral solution, is commercialized in the U.S. by its U.S. subsidiary Greenwich Biosciences for the treatment of seizures associated with Lennox-Gastaut syndrome (LGS), Dravet syndrome, or tuberous sclerosis complex (TSC) in patients one year of age and older. This product has received approval in the European Union under the tradename EPIDYOLEX<sup>\u00ae<\/sup> for the adjunctive treatment of seizures associated with LGS or Dravet syndrome in conjunction with clobazam in patients two years and older and is under EMA review for the treatment of TSC. The Company has a deep pipeline of additional cannabinoid product candidates, in particular nabiximols, for which the Company is advancing multiple late-stage clinical programs in order to seek FDA approval in the treatment of spasticity associated with multiple sclerosis and spinal cord injury. The Company has additional cannabinoid product candidates in clinical trials for autism and schizophrenia. For further information, please visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=aIFIFX6PhIu_3gvLYSIqTFUOB6l99DMediXTNumPAeFD3_7YpSCHlQiuuxeIGX9WjUKL2HqjT6NOup3mXuZSyg==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><u>www.gwpharm.com<\/u><\/a>.<\/p>\n<p align=\"justify\">\n        <strong>Enquiries:<\/strong>\n      <\/p>\n<table style=\"border-collapse: collapse;width:100%;border-collapse:collapse\">\n<tr>\n<td style=\"max-width:35%;width:35%;min-width:35%;text-align: justify;vertical-align: middle;vertical-align: top\">\n            <strong>GW Pharmaceuticals plc<\/strong>\n          <\/td>\n<td style=\"max-width:65%;width:65%;min-width:65%;text-align: justify;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify;vertical-align: middle;vertical-align: top\">Scott Giacobello, Chief Financial Officer<\/td>\n<td style=\"text-align: justify;vertical-align: middle;vertical-align: top\">760 795 2200<\/td>\n<\/tr>\n<\/table>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5NzcyMiMzODU4OTkyIzIwMjc4ODg=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/31d8e5e6-517d-497a-a749-ff68a7e2a443\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>LONDON and CARLSBAD, Calif., Dec. 07, 2020 (GLOBE NEWSWIRE) &#8212; GW Pharmaceuticals plc (NASDAQ: GWPH, GW, the Company or the Group), a world leader in the science, development, and commercialization of cannabinoid prescription medicines, today announced that the Company will present at the Needham Virtual Epilepsy &amp; Pain \u2013 Specialty CNS Therapeutics Conference on Thursday, December 10, 2020 at 11:00am EST. A live audio webcast of the presentation will be available through GW\u2019s corporate website at www.gwpharm.com in the Investors section under Events &amp; Presentations. A replay will be available soon after the live presentation. About GW Pharmaceuticals plc and Greenwich Biosciences, Inc. Founded in 1998, GW is a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/gw-pharmaceuticals-to-present-at-the-2020-needham-virtual-epilepsy-pain-specialty-cns-therapeutics-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;GW Pharmaceuticals to Present at the 2020 Needham Virtual Epilepsy &amp; Pain \u2013 Specialty CNS Therapeutics Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-394038","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>GW Pharmaceuticals to Present at the 2020 Needham Virtual Epilepsy &amp; Pain \u2013 Specialty CNS Therapeutics Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/gw-pharmaceuticals-to-present-at-the-2020-needham-virtual-epilepsy-pain-specialty-cns-therapeutics-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"GW Pharmaceuticals to Present at the 2020 Needham Virtual Epilepsy &amp; Pain \u2013 Specialty CNS Therapeutics Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"LONDON and CARLSBAD, Calif., Dec. 07, 2020 (GLOBE NEWSWIRE) &#8212; GW Pharmaceuticals plc (NASDAQ: GWPH, GW, the Company or the Group), a world leader in the science, development, and commercialization of cannabinoid prescription medicines, today announced that the Company will present at the Needham Virtual Epilepsy &amp; Pain \u2013 Specialty CNS Therapeutics Conference on Thursday, December 10, 2020 at 11:00am EST. A live audio webcast of the presentation will be available through GW\u2019s corporate website at www.gwpharm.com in the Investors section under Events &amp; Presentations. A replay will be available soon after the live presentation. About GW Pharmaceuticals plc and Greenwich Biosciences, Inc. Founded in 1998, GW is a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from &hellip; Continue reading &quot;GW Pharmaceuticals to Present at the 2020 Needham Virtual Epilepsy &amp; Pain \u2013 Specialty CNS Therapeutics Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/gw-pharmaceuticals-to-present-at-the-2020-needham-virtual-epilepsy-pain-specialty-cns-therapeutics-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-12-07T12:03:13+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5NzcyMiMzODU4OTkyIzIwMjc4ODg=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gw-pharmaceuticals-to-present-at-the-2020-needham-virtual-epilepsy-pain-specialty-cns-therapeutics-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gw-pharmaceuticals-to-present-at-the-2020-needham-virtual-epilepsy-pain-specialty-cns-therapeutics-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"GW Pharmaceuticals to Present at the 2020 Needham Virtual Epilepsy &amp; Pain \u2013 Specialty CNS Therapeutics Conference\",\"datePublished\":\"2020-12-07T12:03:13+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gw-pharmaceuticals-to-present-at-the-2020-needham-virtual-epilepsy-pain-specialty-cns-therapeutics-conference\\\/\"},\"wordCount\":310,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gw-pharmaceuticals-to-present-at-the-2020-needham-virtual-epilepsy-pain-specialty-cns-therapeutics-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA5NzcyMiMzODU4OTkyIzIwMjc4ODg=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gw-pharmaceuticals-to-present-at-the-2020-needham-virtual-epilepsy-pain-specialty-cns-therapeutics-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gw-pharmaceuticals-to-present-at-the-2020-needham-virtual-epilepsy-pain-specialty-cns-therapeutics-conference\\\/\",\"name\":\"GW Pharmaceuticals to Present at the 2020 Needham Virtual Epilepsy &amp; Pain \u2013 Specialty CNS Therapeutics Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gw-pharmaceuticals-to-present-at-the-2020-needham-virtual-epilepsy-pain-specialty-cns-therapeutics-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gw-pharmaceuticals-to-present-at-the-2020-needham-virtual-epilepsy-pain-specialty-cns-therapeutics-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA5NzcyMiMzODU4OTkyIzIwMjc4ODg=\",\"datePublished\":\"2020-12-07T12:03:13+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gw-pharmaceuticals-to-present-at-the-2020-needham-virtual-epilepsy-pain-specialty-cns-therapeutics-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gw-pharmaceuticals-to-present-at-the-2020-needham-virtual-epilepsy-pain-specialty-cns-therapeutics-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gw-pharmaceuticals-to-present-at-the-2020-needham-virtual-epilepsy-pain-specialty-cns-therapeutics-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA5NzcyMiMzODU4OTkyIzIwMjc4ODg=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA5NzcyMiMzODU4OTkyIzIwMjc4ODg=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gw-pharmaceuticals-to-present-at-the-2020-needham-virtual-epilepsy-pain-specialty-cns-therapeutics-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"GW Pharmaceuticals to Present at the 2020 Needham Virtual Epilepsy &amp; Pain \u2013 Specialty CNS Therapeutics Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"GW Pharmaceuticals to Present at the 2020 Needham Virtual Epilepsy &amp; Pain \u2013 Specialty CNS Therapeutics Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/gw-pharmaceuticals-to-present-at-the-2020-needham-virtual-epilepsy-pain-specialty-cns-therapeutics-conference\/","og_locale":"en_US","og_type":"article","og_title":"GW Pharmaceuticals to Present at the 2020 Needham Virtual Epilepsy &amp; Pain \u2013 Specialty CNS Therapeutics Conference - Market Newsdesk","og_description":"LONDON and CARLSBAD, Calif., Dec. 07, 2020 (GLOBE NEWSWIRE) &#8212; GW Pharmaceuticals plc (NASDAQ: GWPH, GW, the Company or the Group), a world leader in the science, development, and commercialization of cannabinoid prescription medicines, today announced that the Company will present at the Needham Virtual Epilepsy &amp; Pain \u2013 Specialty CNS Therapeutics Conference on Thursday, December 10, 2020 at 11:00am EST. A live audio webcast of the presentation will be available through GW\u2019s corporate website at www.gwpharm.com in the Investors section under Events &amp; Presentations. A replay will be available soon after the live presentation. About GW Pharmaceuticals plc and Greenwich Biosciences, Inc. Founded in 1998, GW is a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from &hellip; Continue reading \"GW Pharmaceuticals to Present at the 2020 Needham Virtual Epilepsy &amp; Pain \u2013 Specialty CNS Therapeutics Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/gw-pharmaceuticals-to-present-at-the-2020-needham-virtual-epilepsy-pain-specialty-cns-therapeutics-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2020-12-07T12:03:13+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5NzcyMiMzODU4OTkyIzIwMjc4ODg=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gw-pharmaceuticals-to-present-at-the-2020-needham-virtual-epilepsy-pain-specialty-cns-therapeutics-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gw-pharmaceuticals-to-present-at-the-2020-needham-virtual-epilepsy-pain-specialty-cns-therapeutics-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"GW Pharmaceuticals to Present at the 2020 Needham Virtual Epilepsy &amp; Pain \u2013 Specialty CNS Therapeutics Conference","datePublished":"2020-12-07T12:03:13+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gw-pharmaceuticals-to-present-at-the-2020-needham-virtual-epilepsy-pain-specialty-cns-therapeutics-conference\/"},"wordCount":310,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gw-pharmaceuticals-to-present-at-the-2020-needham-virtual-epilepsy-pain-specialty-cns-therapeutics-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5NzcyMiMzODU4OTkyIzIwMjc4ODg=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gw-pharmaceuticals-to-present-at-the-2020-needham-virtual-epilepsy-pain-specialty-cns-therapeutics-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/gw-pharmaceuticals-to-present-at-the-2020-needham-virtual-epilepsy-pain-specialty-cns-therapeutics-conference\/","name":"GW Pharmaceuticals to Present at the 2020 Needham Virtual Epilepsy &amp; Pain \u2013 Specialty CNS Therapeutics Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gw-pharmaceuticals-to-present-at-the-2020-needham-virtual-epilepsy-pain-specialty-cns-therapeutics-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gw-pharmaceuticals-to-present-at-the-2020-needham-virtual-epilepsy-pain-specialty-cns-therapeutics-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5NzcyMiMzODU4OTkyIzIwMjc4ODg=","datePublished":"2020-12-07T12:03:13+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gw-pharmaceuticals-to-present-at-the-2020-needham-virtual-epilepsy-pain-specialty-cns-therapeutics-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/gw-pharmaceuticals-to-present-at-the-2020-needham-virtual-epilepsy-pain-specialty-cns-therapeutics-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gw-pharmaceuticals-to-present-at-the-2020-needham-virtual-epilepsy-pain-specialty-cns-therapeutics-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5NzcyMiMzODU4OTkyIzIwMjc4ODg=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5NzcyMiMzODU4OTkyIzIwMjc4ODg="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gw-pharmaceuticals-to-present-at-the-2020-needham-virtual-epilepsy-pain-specialty-cns-therapeutics-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"GW Pharmaceuticals to Present at the 2020 Needham Virtual Epilepsy &amp; Pain \u2013 Specialty CNS Therapeutics Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/394038","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=394038"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/394038\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=394038"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=394038"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=394038"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}